Population Characteristics
| Characteristic | Mean | Median ± SD | Range | Frequency | % |
| Age (y) | 68.9 | 70 ± 6.7 | 47–84 | ||
| PSA (ng/mL) | 1 | 1.1 ± 0.6 | 0.2–2 | ||
| PSAdt (mo) | 8.5 | 6 ± 8.6 | 0.3–48 | ||
| PSAVel (ng/mL/y) | 8.2 | 3.7 ± 1.7 | 0.1–15.6 | ||
| GS | Median, 7 | 4–9 | |||
| TNM | T2cN0M0 | T2aN0M0, T4N0M0 | |||
| Primary therapies | |||||
| RP | 487 | 80.5 | |||
| RP + adjuvant RT | 118 | 19.5 | |||
| Ongoing ADT | 148 | 24.5 | |||
| Time to relapse (mo) | |||||
| <12 | 19.2 | 116 | |||
| >12 | 80.8 | 489 |
n = 605 patients.